SequelSEC

AVAI BIO, INC. AVAI

Services-Computer Processing & Data Preparation · CIK 0001740797 · Fiscal year ends 0331

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2023-03-31
Operating income
Unavailable
Fiscal year ended 2023-03-31
Free cash flow
Unavailable
Fiscal year ended 2023-03-31

Valuation, from the filing

Public float$36.85MMarket value of stock held by non-affiliates, as stated on the cover page for 2026-03-31
Float per share$0.24Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2026-03-31, not today.

How this compares in its industry

Percentile among the Services-Computer Processing & Data Preparation filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Gross margin-14.6%2th
Current ratio0.12x12th
Net margin-126.3%17th
Operating margin-126.3%17th

This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from AVAI BIO, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Computer Processing & Data Preparation.

Income

AVAI BIO, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2023-03-31
RevenueUnavailable
Cost of revenueUnavailable
Gross profitUnavailable
Operating incomeUnavailable
Net incomeUnavailable
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

AVAI BIO, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2023-03-31
Cash & equivalents$107.47K
Total assets$241.46K
Current assets$107.58K
Total liabilities$874.72K
Current liabilities$874.72K
Total equity incl. NCI-$633.26K
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$236.90K

Cash flow

AVAI BIO, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2023-03-31
Operating cash flowUnavailable
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flowUnavailable
Net change in cashUnavailable
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

AVAI BIO, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2023-03-31
Free cash flowUnavailable
Gross marginUnavailable
Operating marginUnavailable
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.12x
Revenue YoY growthUnavailable
Net marginUnavailable
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open AVAI in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-K · Filed 2026-07-14View SEC filing
10-Q · Filed 2026-02-12View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-12View SEC filing
10-K · Filed 2025-07-08View SEC filing

Companies in the same industry

ADP ALIS APLD AUUD BHIC BIRD CARG CARS CLVT CRCW DTCX DTST

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.